Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Disposable Incontinence Products Market –Insights
Disposable incontinence products include, protective incontinence garments, urine bags, and urinary catheter. Protective incontinence garments aid in maintaining bladder leakage and hold urine, block odor, and keep moisture barrier from the skin. Protective incontinence garments include, cloth adult diapers, disposable adult diapers, disposable pads & liners, belted & beltless under garments, and disposable underpads/sheet.
The global disposable incontinence products market is estimated to account for US$ 9,367.1 Mn in terms of value in 2018 and is expected to reach US$ 13,939.9 Mn by the end of 2027.
Global Disposable Incontinence Products Market: Drivers
Increasing prevalence of chronic bladder-related diseases is expected to propel growth of the global disposable incontinence products market over the forecast period. For instance, according to International Continence Society, in 2018, 63 million people suffered from urgency urinary incontinence worldwide.
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.
Global Disposable Incontinence Products Market: Restraints
Consumption of disposable products leads to disposable waste, which has an adverse effect on environment. This in turn is expected to hinder growth of the market.
Moreover, reluctance to purchase adult incontinence products is also expected to limit growth of the market. Adults show occasional reluctance in using incontinence products even majority of this population group witness increasing frequency of urination.
Global Disposable Incontinence Products Market: Opportunities
Market players may focus on increasing awareness and break social stigma associated with incontinence through various campaigns and adverts.
Increasing prevalence of bladder cancer is expected to offer lucrative growth opportunities for players in the market. For instance, according to The American Cancer Society, the U.S. is expected to register around 80,470 new cases of bladder cancer (about 61,700 in men and 18,770 in women) and 17,670 deaths from bladder cancer (about 12,870 in men and 4,800 in women) in 2019.
Protective Incontinence Garments segment in the global disposable incontinence products market was valued at US$ 7,739.4 Mn in 2018 and is expected to reach US$ 11,528.4 Mn by 2027 at a CAGR of 4.4% during the forecast period.
Market Trends/Key Takeaways
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2020, Daio Paper Corporation, a paper, pulp, and paperboard manufacturer based in Japan, announced its plans to acquire Özen Ki?isel Bak?m Ürünleri Üretim A.?., a hygiene products manufacturer, and Santher - Fábrica de Papel Santa Therezinha S.A., a manufacturer of personal care products such as adult disposable diapers.
Key players in the market are also focused on launching novel urinary catheters that are designed for increased patient safety. For instance, in February 2019, Safe Medical Design, Inc. received the U.S. Food and Drug Administration (FDA) clearance for its Signal Catheter for commercialization in the U.S.
Regulations for conventional and antimicrobial Foley catheters
- Conventional and antimicrobial Foley catheters are described in the FDA regulations under 21 CFR 876.5130(a), Urological Catheter and Accessories, as a "flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract.“
- The classification for these devices is class II as stated in 21 CFR 876.5130(b) and its product codes are: 78 EZL - catheter, retention type, balloon and 78 MJC - urological catheter (antimicrobial) and accessories.
- A Foley catheter has also been described in the scope of the ASTM F 623-89 standard, as an indwelling balloon-retention catheter used by medical professionals to provide a means of bladder drainage through the urethra
- The catheter is for single use, is intended for short-term (less than 30 days) use, and is retained in the bladder with a balloon inflated with a sterile liquid. Sterile water is generally recommended
- A catheter that is not within the scope of the ASTM F 623-89 standard may merit special attention from the manufacturer as well as FDA
- Specifically excluded from the scope of the ASTM standard are catheters that have three lumens, balloons equal to or larger than 30 cm3, or shaft sizes smaller than 12 Fr or larger than 26 Fr
- Also excluded are catheters for pediatric and nonurethral catheterizations such as nephrostomy, suprapubic cystostomy, ureterostomy, gastrostomy, enemas, etc
- The properties of the catheter that are outside the scope of the standard may enable the catheter to be used for indications that would require additional data to establish safety and effectiveness, including clinical data
- Antimicrobial and hydrophilic coated catheters are excluded from the scope of this standard and the required additional data
Regulations for urine bags
- A urine collector and accessories not intended to be connected to an indwelling catheter, which includes the corrugated rubber sheath, pediatric urine collector, leg bag for external use, urosheath type incontinence device, and the paste-on device for incontinence.
- Class II (special controls): For a urine collector and accessories intended to be connected to an indwelling catheter
- The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to 876.9
- Class I (general controls): For a urine collector and accessories not intended to be connected to an indwelling catheter, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in 876.9
- If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of 820.180, with respect to general requirements concerning records, and 820.198, with respect to complaint files
Global Disposable Incontinence Products Market: Competitive Landscape
Major players operating in the global disposable incontinence products market include, Unicharm Corporation, Paul Hartmann AG, Kimberly-Clark Corporation, B. Braun Melsungen AG, Medtronic PLC, ConvaTec Inc., Theos Medical Systems, Inc., Abena Group, SCA Hygiene Products AB, Medline Industries, Ontex International N.V., C. R. Bard, Inc. (Becton, Dickinson and Company), Mega Soft (Fujian) Hygiene Products Co., Ltd., Fujian Yifa Healthcare Products Co., Ltd., and Fujian Hengan Group Ltd.
Global Disposable Incontinence Products Market: Key Developments
Key players in the market are also focused on gaining reimbursement approval for their products. For instance, in September 2019, Bactiguard’s indwelling urinary catheters (Foleys) received approval for reimbursement in the Netherlands.
Key players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2019, Hollister Incorporated received a 2019 Innovative Technology designation from Vizient, Inc. for its VaPro No Touch Intermittent Catheter – a urinary catheter.